TOBTA - Overview: Tobramycin, Trough, Serum
Monitoring adequate clearance of tobramycin near the end of a dosing cycle
CEASF - Overview: Carcinoembryonic Antigen (CEA), Spinal Fluid
Detecting meningeal carcinomatosis and intradural or extradural infiltration Differentiating brain parenchymal metastasis from adenocarcinoma or squamous-cell carcinoma
CATTR - Overview: Cold Agglutinin Titer, Serum
Detection of cold agglutinins in patients with suspected cold agglutinin disease This test is not recommended to diagnose Mycoplasma pneumoniae infections.
DIA - Overview: Diazepam and Nordiazepam, Serum
Assessing compliance Monitoring for appropriate therapeutic level Assessing diazepam toxicity
PHU_ - Overview: pH, Random, Urine
Assessment of patients with metabolic acidosis Assessment of crystalluria Monitoring the effectiveness of alkalinization or acidification of urine for certain medical conditions (eg, treatment of uric acid nephrolithiasis)
PERAM - Overview: Perampanel, Serum
Monitoring serum concentration of perampanel, in specific clinical conditions (ie, severe kidney impairment, mild to moderate hepatic impairment, and end-stage kidney disease) Assessing compliance Assessing potential toxicity
RPHOC - Overview: Phosphorus, Random, Urine
Evaluation of hypo- or hyperphosphatemic states Evaluation of patients with nephrolithiasis
FLEC - Overview: Flecainide, Serum
Optimizing flecainide dosage Assessing flecainide toxicity Monitoring compliance
HBEL0 - Overview: Hemoglobin Electrophoresis Summary Interpretation
Incorporating and summarizing results into an overall evaluation for the HBEL1 / Hemoglobin Electrophoresis Evaluation, Blood
PVLE - Overview: Paraneoplastic Vision Loss Evaluation, Serum
Evaluating patients with rapidly progressive vision loss where a paraneoplastic cause for vision loss (retinopathy or optic neuritis with other findings [eg, retinitis] is suspected) Evaluating patients with small-cell carcinoma who...
PNBX - Overview: Peripheral Nerve Pathology Consultation
Evaluating diseases of the nerve and disorders that affect nerve function
HIAAR - Overview: 5-Hydroxyindoleacetic Acid, Random, Urine
Biochemical diagnosis and monitoring of intestinal carcinoid syndrome using random urine specimens
RFPN - Overview: Rheumatoid Factor Panel, Serum
Evaluating patients at-risk of rheumatoid arthritis (RA) or features of inflammatory arthritis Differentiating the antibody isotype profile in patients positive for rheumatoid factor (RF) Aid in the risk stratification of RF-seropositive...
HV1CD - Overview: HIV-1 and HIV-2 Antibodies for Cadaveric or Hemolyzed Specimens, Serum
Diagnosing HIV-1 and/or HIV-2 infection in cadaveric or hemolyzed serum specimens from symptomatic patients with or without risk factors for HIV infection This test is not offered as a screening or confirmatory test for blood donor...
GALT - Overview: Galactose-1-Phosphate Uridyltransferase, Blood
Diagnosis of galactose-1-phosphate uridyltransferase deficiency, the most common cause of galactosemia Confirmation of abnormal state newborn screening results
TLYME - Overview: Lyme IgM and IgG, Whole Cell Sonicate, ELISA, Serum
Supplemental testing for samples with positive or equivocal first-tier test results for antibodies to Lyme disease causing Borrelia species This test should not be used as a screening procedure for the general population.
WBGDD - Overview: Beta-Globin Gene Cluster, Deletion/Duplication, Varies
Determining the etiology of hereditary persistence of fetal hemoglobin (HPFH), delta-beta thalassemia, or other large deletions involving the beta-globin gene cluster Diagnosing less common causes of beta thalassemia; these large...
MSH6 - Overview: MSH6 Immunostain, Technical Component Only
Identifying patients at high risk for having hereditary nonpolyposis colorectal cancer, also known as Lynch syndrome, in an immunopanel including MSH6 and other mismatch repair markers Evaluation of tumor tissue to identify patients at...
TPPA - Overview: Syphilis Antibody, Treponema pallidum Particle Agglutination, Serum
An aid to resolve discrepant results between screening treponemal and non-treponemal assays This test is not recommended for general screening purposes for syphilis. This test should not be used to evaluate response to therapy. This test...
BRMLH - Overview: MLH1 Hypermethylation and BRAF Mutation Analysis, Tumor
An adjunct to MSI / Microsatellite Instability (MSI), Tumor and IHC / Mismatch Repair (MMR) Protein Immunohistochemistry Only, Tumor testing, when colon tumor demonstrates microsatellite instability (MSI-H) and loss of MLH1 protein...
CPR - Overview: C-Peptide, Serum
Diagnostic workup of hypoglycemia: -Diagnosis of factitious hypoglycemia due to surreptitious administration of insulin -Evaluation of possible insulinoma -Surrogate measure for the absence or presence of physiological suppressibility of...
EHBAP - Overview: Ehrlichia/Babesia Antibody Panel, Immunofluorescence, Serum
As an adjunct in the diagnosis of infection with Anaplasma phagocytophilum, Ehrlichia chaffeensis, or Babesia microti Seroepidemiological surveys of the prevalence of the infection in certain populations
CDAU7 - Overview: Drug Abuse Survey with Confirmation, Panel 9, Random, Urine
Detecting drug abuse involving, amphetamines, barbiturates, benzodiazepines, cocaine, ethanol, methadone, opiates, phencyclidine, and tetrahydrocannabinol This test is intended to be used in a setting where the test results can be used...
HV1CM - Overview: HIV-1 and HIV-2 Antibody Screen for Hemolyzed Specimens, Serum
Screening cadaveric or hemolyzed serum specimens for HIV-1 and/or HIV-2 infection in nonsymptomatic patients with or without risk factors for HIV infection This test is not offered as a screening or confirmatory test for blood donor...
RRPRS - Overview: Rapid Plasma Reagin Screen with Reflex to Titer, Serum
Aid for the diagnosis of infection with Treponema pallidum Rapid plasma reagin testing following a positive treponemal antibody test This test is not useful as a screening or confirmatory test for blood donor specimens.
PN10X - Overview: Pain Clinic Survey 10, Chain of Custody, Random, Urine
Detecting drug use involving amphetamines, barbiturates, benzodiazepines, cocaine, methadone, opiates, phencyclidine, and carboxy-tetrahydrocannabinol This chain-of-custody test is intended to be used in a setting where the test results...
PENTS - Overview: Pentobarbital, Serum
Monitoring of pentobarbital therapy treatment
VLTU - Overview: Volatile Screen, Random, Urine
Detecting the presence of acetone, methanol, isopropanol, or ethanol in urine with subsequent quantitation
NEGCT - Overview: Negative Control, Technical Component Only
Qualitative detection of protein expression within cells in paraffin-embedded tissues
ROC - Overview: Rubeola (Measles) Antibodies, IgG and IgM, Spinal Fluid
Diagnosing central nervous system rubeola (measles) virus infection and/or subacute sclerosing panencephalitis
IGD - Overview: Immunoglobulin D (IgD), Serum
Providing information on the humoral immune status Identifying an IgD monoclonal gammopathy
FXIII - Overview: Factor XIII (13), Screen, Plasma
Screening for factor XIII deficiency
10_IS - Overview: Factor X Inhibitor Screen, Plasma
Detecting the presence of a specific factor inhibitor directed against coagulation factor X
F7_IS - Overview: Factor VII Inhibitor Screen, Plasma
Detecting the presence of a specific factor inhibitor directed against coagulation factor VII
F2_IS - Overview: Factor II Inhibitor Screen, Plasma
Detecting the presence of a specific factor inhibitor directed against coagulation factor II
11_IS - Overview: Factor XI Inhibitor Screen, Plasma
Detecting the presence of a specific factor inhibitor directed against coagulation factor XI
LID - Overview: Lidocaine, Serum
Assessing optimal lidocaine dosing during the acute management of ventricular arrhythmias following myocardial infarction or during cardiac manipulation such as surgery Assessing potential lidocaine toxicity
LEVE - Overview: Levetiracetam, Serum
Monitoring serum concentration of levetiracetam, particularly in patients with kidney disease Assessing compliance with levetiracetam therapy Assessing potential toxicity of levetiracetam
ADULT - Overview: Adulterants Survey, Random, Urine
Assessment of possible adulteration of a urine specimen submitted for drug of abuse testing Providing the creatinine concentration for normalization purposes
ABYSR - Overview: Antibody Screen with Reflexed Antibody Identification, Blood
Detection of allo- or autoantibodies directed against red blood cell antigens in the settings of pretransfusion testing Evaluation of transfusion reactions Evaluation of hemolytic anemia
HCO3 - Overview: Bicarbonate, Serum
Diagnosis and treatment of acid-base imbalance in respiratory and metabolic systems
RCTUR - Overview: Creatinine, Random, Urine
Calculation of creatinine clearance, a measure of renal function, when used in conjunction with serum creatinine Normalization of urinary analytes by creatinine concentration to account for the variation in urinary concentrations between...
MTXSG - Overview: Methotrexate Post Glucarpidase, Serum
Monitoring methotrexate concentrations post-glucarpidase therapy Documenting failure to respond that may be due to noncompliance Guiding dosage adjustments in patients with kidney failure
PBR - Overview: Phenobarbital, Serum
Monitoring for appropriate therapeutic concentration of phenobarbital Assessing compliance or toxicity
PNYF - Overview: Phenytoin, Free, Serum
Monitoring for appropriate therapeutic concentration of free phenytoin: free phenytoin level is the best indicator of adequate therapy in renal failure Assessing compliance and toxicity
RNAUR - Overview: Sodium, Random, Urine
Assessing acid-base balance, water balance, water intoxication, and dehydration
MEPHS - Overview: Mephobarbital and Phenobarbital, Serum
Monitoring of mephobarbital and phenobarbital therapy
HGCU - Overview: Mercury/Creatinine Ratio, Random, Urine
Detecting mercury toxicity using random urine specimens
CULAF - Overview: Culture for Genetic Testing, Amniotic Fluid
Producing amniocyte cultures that can be used for genetic analysis
PA - Overview: Procainamide and N-Acetylprocainamide, Serum
Monitoring therapy with procainamide Assessing compliance Evaluating procainamide toxicity
Week in Review: February 3 - Insights
Include: President Biden to End Covid-19 Emergencies On May 11, and Children’s Minnesota Received $3 Million Grant To Address Pediatric Health Disparities....
Top 3 reasons to join us at Leveraging the Laboratory 2025 - Insights
variety of perspectives pertaining to health system laboratory outreach programs. Here are the top 3 reasons why you should attend....
Leveraging the Laboratory Archives - Page 3 of 3 - Insights
Skip to Content MayoACCESS MayoLINK...
Detection of (1→3)-𝝱-D-glucan as a Marker of Invasive Fungal Disease - Insights
In this month’s “Hot Topic,” Elitza Theel, Ph.D., will discuss the detection of (1→3)-β-D-glucan (BDG) in serum as a biomarker for the presence of invasive fungal infections....
Phlebotomy Modules: Module 3 | Insights
Skip to Content MayoACCESS MayoLINK...